SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SC who wrote (317)4/11/1998 3:07:00 PM
From: Zeev Hed  Read Replies (1) of 1321
 
SC, thank you for the very detailed response. By the that "excited Oxygen state" to the best of my knowledge, is not really a radical, but excited molecular oxygen, specifically delta singlet oxygen, an excited species with an average half life time of 40 seconds (or is it minutes?) (in vacuum, much shorter within tissues, of course).

When using selectively absorbed drugs activated with specific laser beams, I presume the practitioner must scan the spot over the area affected, how does he knows, where the beam has already impinged on the tissues and what parts of the retina still need be irradiated? Typically, the beam, as you stated is between .o5 to .5 mm while the target tissue must be much larger. I am also interested in the quantum yield for activation (namely, in essence, how many photons need be delivered before the activation process can be assumed to have taken place statistically everywhere).

Thanks again.

Zeev
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext